Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NuCana plcfiledCriticalNuCana plc
Priority to CL2018001731ApriorityCriticalpatent/CL2018001731A1/en
Publication of CL2018001731A1publicationCriticalpatent/CL2018001731A1/en
COMBINACIÓN QUE COMPRENDE GEMCITABINA-[FENIL-BENZOXI-L-ALANINILO]-FOSFATO Y UN AGENTE ANTI-CÁNCER BASADO EN PLATINO SELECCIONADO DE CISPLATINO, PICOPLATINO, LIPOLATINO Y TRIPLATINO; FORMULACIÓN FARMACÉUTICA QUE LA COMPRENDE; KIT; Y USO DE LA COMBINACIÓN PARA EL TRATAMIENTO DEL CÁNCER.COMBINATION INCLUDING GEMCITABINE- [PHENYL-BENZOXI-L-ALANINYL] -PHOSPHATE AND AN ANTI-CANCER AGENT BASED ON SELECTED CISPLATINO, PICOPLATINO, LIPOLATINO AND TRIPLATINO PLATINUM; PHARMACEUTICAL FORMULATION THAT UNDERSTANDS IT; KIT; AND USE OF THE COMBINATION FOR THE TREATMENT OF CANCER.